Treatments including TMZ induced stronger cell death in p53-wt compared to p53-mut cell lines with similar MGMT promoter methylation status (55.6–75%) which is in accordance with the reported role of p53 in cancer drug resistance [45]. Here, TP53 is linked to cancer.